NASDAQ$CME

CME Group · Q3 2025 earnings

Q3 2025 earnings · · Before market open · Investor relations

Briefing

CME Group reported Q3 2025 total revenues of $1.54B with net income of $856M and diluted EPS of $2.37.

Total revenues were $1.54 billion on higher average daily volume and strong interest income on collateral. Net income was $856 million; diluted EPS was $2.37. Rates, equities, and metals volumes benefited from macro volatility.

  • Q3 total revenues $1.54B.
  • Net income $856M; diluted EPS $2.37.
  • ADV and market data revenue rose with volatility.
  • Collateral investment income remains a meaningful earnings lever.

Headline financials

Total Revenue

$1.54B

Previous: $1.58B-3.0%
EPS (adj)

$2.49

Previous: $2.50-0.4%
Average Daily Volume

25.3M

Previous: 28.3M-10.5%
Average Rate Per Contract

$0.70

Previous: $0.67+5.4%
Capital Expenditures

-$51M

Previous: -$67.8M+24.8%
Free Cash Flow

$857M

Previous: $845M+1.4%
Net Income

$908M

Previous: $913M-0.5%
Operating Income

$973M

Previous: $1.02B-5.0%
Gross Profit

$1.54B

Previous: $1.58B-3.0%
Cash & Equivalents

$2.45B

Previous: $2.32B+5.4%
Total Assets

$187B

Previous: $138B+35.8%

Revenue & EPS history

CME Group · Revenue · Quarterly

$1.54B

Q3 2025-3%vs Q3 2024
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Revenue by segment

CME Group · $1.34B total across 3 segments · Q3 2023

  • Clearing and transaction fees
    $1.09B+8.7%
  • Market data and information services
    $168M+8.6%
  • Other
    $84.7M+13.1%

Forward guidance

The filing discusses CME Group's outlook, including capital allocation, operating priorities, and market risks relevant to the reported quarter.

Tailwinds

  • CME Group cites operational priorities and demand trends supporting the outlook.
  • Balance sheet and liquidity actions aim to fund growth and returns.

Headwinds

  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-0.1%

Avg return

Earnings day

-0.5%

Avg return

5 days after

+1.9%

Avg return

30 days after

45%

33 / 73 earnings

Positive

+5.8%

Q1 2022

Best reaction

-6.8%

Q3 2011

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.7%-0.9%+2.4%
Q4 2025-0.3%+4.8%+8.2%
Q3 2025-0.3%+0.9%+1.7%
Q2 2025+0.3%-0.9%-4.2%
Q1 2025-1.5%+0.9%+7.0%
Q4 2024+3.0%+1.5%+7.0%
Q3 2024+1.6%+0.9%+1.3%
Q2 2024+1.0%+0.7%+4.9%
Q1 2024-2.0%-3.3%-0.9%
Q4 2023+1.7%+2.3%+4.9%
Q3 2023+0.6%-1.4%+1.4%
Q2 2023+3.9%+4.0%+6.3%
Q1 2023-1.8%-0.6%-5.9%
Q4 2022+2.9%+4.2%-1.8%
Q3 2022-1.7%-1.4%-0.5%
Q2 2022-2.1%-3.9%-3.6%
Q1 2022+5.8%+1.6%-6.3%
Q4 2021+1.1%-0.9%-6.4%
Q3 2021-0.4%-0.4%+1.3%
Q2 2021+1.3%-0.2%-5.7%
Q1 2021-0.5%-0.5%+6.8%
Q4 2020-4.8%-4.0%+8.9%
Q3 2020-5.9%-4.5%+9.6%
Q2 2020-1.7%-1.8%+6.6%
Q1 2020-3.3%-6.4%-0.9%
Q4 2019-1.6%+0.7%-14.0%
Q3 2019+2.4%-2.0%+0.9%
Q2 2019+1.7%+2.3%+10.1%
Q1 2019-3.4%-0.4%+7.4%
Q4 2018-2.8%-3.4%-5.7%
Q3 2018-1.3%+0.8%+4.5%
Q2 2018-2.4%-6.1%-0.1%
Q1 2018-2.3%-2.8%-0.9%
Q4 2017+3.7%+2.7%+8.3%
Q3 2017+2.8%+2.5%+6.0%
Q2 2017+1.3%+2.6%+2.6%
Q1 2017-3.2%-2.3%-1.7%
Q4 2016-0.8%-1.8%+2.6%
Q3 2016-2.8%-3.1%+9.7%
Q2 2016-0.5%+0.6%+3.1%
Q1 2016-2.7%
Q4 2015+4.5%
Q3 2015-1.5%
Q2 2015-1.0%
Q1 2015+1.8%
Q4 2014+5.6%
Q3 2014+2.4%
Q2 2014-2.2%
Q1 2014-1.2%
Q4 2013+0.5%
Q3 2013-1.4%
Q2 2013-2.4%
Q1 2013+0.8%
Q4 2012-2.7%
Q3 2012-2.0%
Q2 2012+2.4%
Q1 2012-1.7%
Q4 2011-0.1%
Q2 2011-0.1%
Q3 2011-6.8%
Q1 2011+0.7%
Q4 2010-2.2%
Q2 2010-2.2%
Q3 2010-0.4%
Q1 2009+3.6%
Q1 2010+1.1%
Q2 2009+1.9%
Q4 2007+1.9%
Q4 2009+1.9%
Q3 2008+2.5%
Q3 2009+2.5%
Q2 2008+0.4%
Q4 2008+0.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro